Dr. Ali Khaki -Loose Regulatory Standards Portend a New Era of Imprecision Oncology- Part 1/2
In this first episode of The Rising Tide Podcast, Dr. Ali Khaki of Stanford University sits down with the Center for Genomic Interpretation to discuss FDA approvals in precision medicine and cancer that miss the mark, what the consequences are for such approvals, and paths forward that could drive improvements in quality and accuracy of precision medicine and, ultimately, patient care.
You Might Like
